ROS-responsive Galactosylated-nanoparticles with Doxorubicin Entrapment for Triple Negative Breast Cancer Therapy

BACKGROUND: Triple negative breast cancer (TNBC) is one of the most aggressive tumors with high metastasis and mortality, which constitutes 15~20% of all breast cancers. Chemotherapy remains main therapeutic option in the treatment of patients with TNBC. METHODS: We developed reactive oxygen species...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jingyi, Li, Kangkang, Zang, Xinlong, Xie, Yi, Song, Jinxiao, Chen, Xuehong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040171/
https://www.ncbi.nlm.nih.gov/pubmed/36987427
http://dx.doi.org/10.2147/IJN.S396087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040171/
https://www.ncbi.nlm.nih.gov/pubmed/36987427
http://dx.doi.org/10.2147/IJN.S396087

Ejemplares similares